OFFICE OF FISCAL ANALYSIS
Legislative Office Building, Room 5200
Hartford, CT 06106 (860) 240-0200
http://www.cga.ct.gov/ofa
sSB-1102
AN ACT CONCERNING PHARMACIES AND PHARMACISTS.
As Amended by Senate "A" (LCO 7349)
Senate Calendar No.: 150
Primary Analyst: RDP 5/5/23
Contributing Analyst(s): ME
OFA Fiscal Note
State Impact:
Agency Affected Fund-Effect FY 24 $ FY 25 $
Public Health, Dept. IF - Savings 25,000 25,000
Public Health, Dept. IF - Cost 25,000 25,000
TOTAL IF – None None None
Note: IF=Insurance Fund
Municipal Impact: None
Explanation
Section 17, which requires the Department of Public Health to
establish a statewide human immunodeficiency virus pre- and post-
exposure prophylaxis drug assistance program, using appropriated
AIDS Services account funding equal to or greater than $25,000
annually, and eliminates a victims of sexual assault post-exposure
prophylaxis program that costs $25,000 annually, results in a net zero
fiscal impact to the agency.
Sections 1 - 16 make various changes to statutes concerning
pharmacists and consumer access to medications resulting in no fiscal
impact to the State or municipalities.
Senate “A” struck the language of the underlying bill and replaced it
with language that resulted in the fiscal impact described above.
The Out Years
There is no fiscal impact to the State or municipalities anticipated in 2023SB-01102-R01-FN.DOCX Page 2 of 2
the out years from the bill as amended.
The preceding Fiscal Impact statement is prepared for the benefit of the members of the General Assembly, solely
for the purposes of information, summarization and explanation and does not represent the intent of the General
Assembly or either chamber thereof for any purpose. In general, fiscal impacts are based upon a variety of
informational sources, including the analyst’s professional knowledge. Whenever applicable, agency data is
consulted as part of the analysis, however final products do not necessarily reflect an assessment from any
specific department.